Cargando…

Heterobivalent Agents Targeting PSMA and Integrin-α(v)β(3)

[Image: see text] Differential expression of surface proteins on normal vs malignant cells provides the rationale for the development of receptor-, antigen-, and transporter-based, cancer-selective imaging and therapeutic agents. However, tumors are heterogeneous, and do not always express what can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shallal, Hassan M., Minn, Il, Banerjee, Sangeeta R., Lisok, Ala, Mease, Ronnie C., Pomper, Martin G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112557/ https://www.ncbi.nlm.nih.gov/pubmed/24410012 http://dx.doi.org/10.1021/bc4005377

Ejemplares similares

A Modular Strategy to Prepare Multivalent Inhibitors of Prostate-Specific Membrane Antigen (PSMA)
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2011)

A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
por: Chen, Ying, et al.
Publicado: (2022)

Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin α(v)β(3) Targeting
por: Braun, Diana, et al.
Publicado: (2023)

Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors
por: Ngen, Ethel J., et al.
Publicado: (2021)

Preclinical Evaluation of a New Series of Albumin-Binding (177)Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics
por: Boinapally, Srikanth, et al.
Publicado: (2023)

A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
por: Boinapally, Srikanth, et al.
Publicado: (2021)

Modular One-Pot Strategy for the Synthesis of Heterobivalent Tracers
por: Bailly, Thibaud, et al.
Publicado: (2023)

Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents
por: Chen, Xiaofei, et al.
Publicado: (2019)

Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFAlin-Modified Peptidic Radioligands Targeting Both Integrin α(v)β(3) and the MC1 Receptor—Suitable for the Specific Visualization of Melanomas?
por: Cheng, Xia, et al.
Publicado: (2021)

Synthesis and biological evaluation of novel N(9)-heterobivalent β-carbolines as angiogenesis inhibitors
por: Guo, Liang, et al.
Publicado: (2019)

Engineered Fragments of the PSMA-Specific 5D3 Antibody and Their Functional Characterization
por: Novakova, Zora, et al.
Publicado: (2020)

Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
por: Judmann, Benedikt, et al.
Publicado: (2020)

Peptide-Based (68)Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer
por: De Silva, Ravindra A., et al.
Publicado: (2018)

Development of [(18)F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
por: Lesniak, Wojciech G., et al.
Publicado: (2019)

Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
por: Shen, Colette J., et al.
Publicado: (2020)

Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitors
por: Rogers, O. C., et al.
Publicado: (2021)

A red-shifted fluorescent substrate for aldehyde dehydrogenase
por: Minn, Il, et al.
Publicado: (2014)

A dextran-based probe for the targeted magnetic resonance imaging of tumours expressing prostate-specific membrane antigen
por: Liu, Guanshu, et al.
Publicado: (2017)

Imaging of carbonic anhydrase IX with an (111)In-labeled dual-motif inhibitor
por: Yang, Xing, et al.
Publicado: (2015)

An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
por: Lesniak, Wojciech G., et al.
Publicado: (2022)

Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
por: Minn, Il, et al.
Publicado: (2019)

(64)Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2014)

Exploration of peptide T7 and its derivative as integrin αvβ3-targeted imaging agents
por: He, Xin, et al.
Publicado: (2015)

There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography
por: Steiger, Katja, et al.
Publicado: (2021)

A specialized integrin-binding motif enables proTGF-β2 activation by integrin αVβ6 but not αVβ8
por: Le, Viet Q., et al.
Publicado: (2023)

Expression of α(v)β(6)integrin in oral leukoplakia
por: Hamidi, S, et al.
Publicado: (2000)

PET Imaging of Integrin αVβ3 Expression
por: Beer, Ambros J., et al.
Publicado: (2011)

Multimodality Imaging of Integrin α(v)β(3) Expression
por: Zhang, Yin, et al.
Publicado: (2011)

Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6
por: Färber, Stefanie Felicitas, et al.
Publicado: (2018)

α(V)β(3) Integrin regulates astrocyte reactivity
por: Lagos-Cabré, Raúl, et al.
Publicado: (2017)

Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression
por: Quaglia, Fabio, et al.
Publicado: (2021)

αV-class integrins exert dual roles on α5β1 integrins to strengthen adhesion to fibronectin
por: Bharadwaj, Mitasha, et al.
Publicado: (2017)

TGFβ(1 )signaling via α(V)β(6 )integrin
por: Kracklauer, Martin P, et al.
Publicado: (2003)

Gadolinium-based contrast agent accelerates the migration of astrocyte via integrin αvβ3 signaling pathway
por: Ariyani, Winda, et al.
Publicado: (2022)

Integrins α(v)β(3) and α(v)β(5) as prognostic, diagnostic, and therapeutic targets in gastric cancer
por: Böger, Christine, et al.
Publicado: (2014)

Enhancement of Radiotherapy with Human Mesenchymal Stem Cells Containing Gold Nanoparticles
por: Pullambhatla, Mrudula, et al.
Publicado: (2020)

[(64)Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
por: Minn, Il, et al.
Publicado: (2016)

A Role for the αvβ3 Integrin in the Transmigration of Monocytes
por: Weerasinghe, Dheepika, et al.
Publicado: (1998)

Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
por: Moore, Kate M., et al.
Publicado: (2014)

Ligand-bound integrin αvβ6 internalisation and trafficking
por: Meecham, Amelia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldbloiu48b52j6djc5co5tkfrn